EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Epistasis at the cell surface: what is the role of Erg3 loss-of-function in acquired echinocandin resistance?

Hans Carolus iD, Judith Díaz-García iD, Vladislav Biriukov iD, Stef Jacobs, Dimitrios Sofras iD, Alicia Pageau, Celia Lobo Romero, Lore Vinken, Pilar Escribano iD, Jesús Guinea, Katrien Lagrou iD, Christian R Landry iD und 2 weitere

mBio · 2025

DOI: 10.1128/mbio.01419-25 ↗

Kurz gefasst

Fallbericht in der Zeitschrift mBio, 2025. Verfasst von Hans Carolus und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Laboratory of Molecular Cell Biology, KU Leuven, Leuven, Flanders, Belgium. Hauptthemen laut MEDLINE: Echinocandins, Drug Resistance, Fungal, Antifungal Agents, Glucosyltransferases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Echinocandins, which target the fungal β-1,3-glucan synthase (Fks), are essential for treating invasive fungal infections, yet resistance is increasingly reported. While resistance typically arises through mutations in Fks hotspots, emerging evidence suggests a contributing role of changes in membrane sterol composition due to ERG3 mutations. Here, we present a clinical case of Nakaseomyces glabratus ( Candida glabrata ) in which combined mutations in ERG3 and FKS2 , but not FKS2 alone, appear to confer echinocandin resistance. Integrated analyses reveal a recurrent association between Erg3 loss-of-function and echinocandin resistance mediated by Fks variation across Candida species, but exclude Erg3 loss-of-function as an independent resistance mechanism. Advances in Fks structural biology and insights into echinocandin-Fks interactions support a model of epistatic cross-talk between membrane sterols and Fks function. Understanding this interaction is crucial, as it may underlie not only acquired echinocandin resistance but also the broader development of multidrug resistance across major antifungal drug classes. IMPORTANCE A clinical case in which the combination of variation in a β‑1,3‑glucan synthase-encoding gene ( FKS2 ) and the sterol desaturase-encoding gene ERG3 seems to underlie echinocandin resistance, prompted us to hypothesize that membrane sterol changes may modulate, rather than independently cause, Fks‑linked resistance. We were able to explore this hypothesis due to recent developments in the field, such as the release of the FungAMR database, which enables global co‑occurrence analyses; AI‑driven variant effect predictors such as Evolutionary Scale Modeling (ESM) that can explore the impact of thousands of ERG3 alleles; the cryo‑EM resolution of the Fks1 protein; and the first mechanistic model of echinocandin‑Fks1 binding. Together, these advances provide the structural and computational framework needed to delineate our hypothesis that specific sterol variants might influence β‑1,3‑glucan synthase function and drug binding. Further surveillance of this potentially epistatic interaction can be of significant clinical importance amid rising multidrug‑resistant infections, as overlooking such interactions could lead to under‑calling resistance and misguided therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EchinocandinsDrug Resistance, FungalAntifungal AgentsGlucosyltransferasesFungal ProteinsEpistasis, GeneticCandida glabrataLoss of Function MutationHumansCandidiasisCell Membrane

Stichwörter der Autor:innen

C-5 sterol desaturase (Erg3)Candida aurisCandida glabrataCandidozyma aurisNakaseomyces glabratusdrug resistance mechanismsechinocandin resistanceechinocandinsepistasisfungal pathogensmultidrug resistancesterolsβ‑1,3‑glucan synthase (Fks)

Substanzen

EchinocandinsAntifungal AgentsGlucosyltransferasesFungal Proteins1,3-beta-glucan synthaseglucan synthase

Autor:innen und Institutionen

  • Department of Biology, Laboratory of Molecular Cell Biology, KU Leuven, Leuven, Flanders, Belgium.
  • Département de Biochimie, de Microbiologie et de Bio-informatique, Faculté des Sciences et de Génie, Université Laval, Québec City, Canada.
  • Institut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Québec City, Canada.
  • PROTEO, Le regroupement québécois de recherche sur la fonction, l'ingénierie et les applications des protéines, Université Laval, Québec City, Canada.
  • Centre de Recherche en Infectiologie (CRI), Université Laval, Québec City, Canada.
  • Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

ORCID-Profile: Hans Carolus, Judith Díaz-García, Vladislav Biriukov, Dimitrios Sofras, Pilar Escribano, Katrien Lagrou, Christian R Landry, Patrick Van Dijck

Zitieren

APA

Carolus, H., Díaz-García, J., Biriukov, V., Jacobs, S., Sofras, D., Pageau, A., Lobo Romero, C., Vinken, L., Escribano, P., Guinea, J., Lagrou, K., Landry, C. R., Gabaldón, T., & Van Dijck, P. (2025). Epistasis at the cell surface: what is the role of Erg3 loss-of-function in acquired echinocandin resistance?. mBio. https://doi.org/10.1128/mbio.01419-25

Vancouver

Carolus H, Díaz-García J, Biriukov V, Jacobs S, Sofras D, Pageau A, et al. Epistasis at the cell surface: what is the role of Erg3 loss-of-function in acquired echinocandin resistance?. mBio. 2025. doi:10.1128/mbio.01419-25

BibTeX
@article{Carolus2025,
  author = {Carolus, Hans and Díaz-García, Judith and Biriukov, Vladislav and Jacobs, Stef and Sofras, Dimitrios and Pageau, Alicia and Lobo Romero, Celia and Vinken, Lore and Escribano, Pilar and Guinea, Jesús and Lagrou, Katrien and Landry, Christian R and Gabaldón, Toni and Van Dijck, Patrick},
  title = {Epistasis at the cell surface: what is the role of Erg3 loss-of-function in acquired echinocandin resistance?},
  journal = {mBio},
  year = {2025},
  doi = {10.1128/mbio.01419-25}
}
Kostenlos starten →